High-drug-loading Capacity of Redox-Activated Biodegradable Nanoplatform for Active Targeted Delivery of Chemotherapeutic Drugs.

Hai Zhang,Jianqin Yan,Heng Mei,Shengsheng Cai,Sai Li,Furong Cheng,Jun Cao,Bin He
DOI: https://doi.org/10.1093/rb/rbaa027
2020-01-01
Regenerative Biomaterials
Abstract:Challenges associated with low-drug-loading capacity, lack of active targeting of tumor cells and unspecific drug release of nanocarriers synchronously plague the success of cancer therapy. Herein, we constructed active-targeting, redox-activated polymeric micelles (HPGssML) self-assembled aptamer-decorated, amphiphilic biodegradable poly (benzyl malolactonate-co-epsilon-caprolactone) copolymer with disulfide linkage and pi-conjugated moieties. HPGssML with a homogenous spherical shape and nanosized diameter (similar to 150nm) formed a low critical micellar concentration (10(-3)mg/mL), suggesting good stability of polymeric micelles. The anticancer drug, doxorubicin (DOX), can be efficiently loaded into the core of micelles with high-drug-loading content via strong pi-pi interaction, which was verified by a decrease in fluorescence intensity and redshift in UV adsorption of DOX in micelles. The redox sensitivity of polymeric micelles was confirmed by size change and in vitro drug release in a reducing environment. Confocal microscopy and flow cytometry assay demonstrated that conjugating aptamers could enhance specific uptake of HPGssML by cancer cells. An in vitro cytotoxicity study showed that the half-maximal inhibitory concentration (IC50) of DOX-loaded HPGssML was two times lower than that of the control group, demonstrating improved antitumor efficacy. Therefore, the multifunctional biodegradable polymeric micelles can be exploited as a desirable drug carrier for effective cancer treatment.
What problem does this paper attempt to address?